Diginex Ltd is a technology-driven business focused on end-to-end software solutions for ESG reporting, including Carbon emissions and supply chain due diligence, together with data solutions... Show more
Diginex Limited shares have traded in a broad, choppy range through late 2026, reflecting the stock's micro-cap profile and the market's attempts to price in a transformative acquisition pipeline. After reaching a short-term high above $1.60 in early September, the stock pulled back and has since fluctuated between roughly $1.12 and $1.46. By mid-November, DGNX had settled near $1.28, up about 8% from the $1.18 close recorded around 30 days earlier.
Investor sentiment remains divided between enthusiasm for Diginex's AI-driven growth strategy and caution over its widening losses, dilution from equity-financed deals, and the compliance requirements that come with trading near Nasdaq's minimum bid threshold.
Diginex Limited is a London-headquartered regulatory technology company that provides ESG, sustainability, and compliance solutions to institutional and corporate clients. Its integrated product suite spans the full sustainability lifecycle, including diginexESG for reporting, Plan A for carbon accounting, Matter for ESG data and investment intelligence, Lumen for supply chain risk and traceability, Apprise for worker-voice engagement, and The Remedy Project for human rights remediation.
The company combines blockchain, artificial intelligence, machine learning, and data analytics to help organizations collect, verify, and report sustainability data. Since its January 2025 Nasdaq listing, Diginex has pursued an acquisition-led strategy, adding Matter DK ApS in October 2025 and both The Remedy Project and Plan A.earth GmbH in January 2026. This consolidation has shifted its operational focus toward Europe and the United Kingdom while broadening its addressable market across software, data, and advisory segments.
The most significant catalyst has been the proposed acquisition of Resulticks Global Companies Pte. Limited, an AI-powered, real-time customer engagement platform. Under the amended agreement, consideration consists of 600 million Diginex ordinary shares issued at $1.75 per share in an all-equity transaction. Shareholders approved the deal at an extraordinary general meeting in early October 2026, and the company subsequently announced an extension of the transaction's long stop date as it works to satisfy remaining closing conditions.
Separately, Diginex launched an enhanced end-to-end supply chain due diligence platform targeting a sustainability software market projected to grow significantly through 2029. Management also introduced a Sustainability Science & Intelligence initiative under newly appointed interim CEO Archana Kotecha, consolidating advisory, regulatory, and methodological expertise across the group. On the financial side, the company announced a $20 million capital raise through ordinary shares and accompanying warrants, reinforcing liquidity ahead of planned integration efforts.
Tickeron's Trending AI Robots page showcases a curated selection of AI-powered trading bots drawn from a much larger universe of automated strategies. Tickeron offers hundreds of AI trading bots that monitor thousands of tickers, but only the top-performing and most relevant bots appear in this featured section. The bots vary widely in strategy, timeframe, and performance metrics, allowing users to compare approaches ranging from short-term technical signals to longer-horizon momentum and swing trading models. For investors following volatile, event-driven names, these tools can provide an additional, data-driven perspective on shifting market conditions and positioning opportunities.
Looking ahead, the successful completion and integration of the Resulticks combination remains the central swing factor for DGNX. Investors should monitor whether all regulatory and Nasdaq listing conditions are satisfied, as well as how management executes a unified, enterprise-grade platform across its acquired assets. Progress toward recurring, higher-margin software and data revenue will be important given the company's expanding cost base and ongoing net losses.
Other factors to watch include further capital-raising activity and its dilutive effect, maintenance of the Nasdaq minimum bid requirement, the pace of global ESG disclosure regulation, and management's ability to deliver cross-selling and cost synergies across Matter, Plan A, The Remedy Project, and Resulticks. As with all early-stage, acquisition-heavy companies, execution risk, integration complexity, and funding needs are likely to remain key drivers of sentiment.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
DGNX saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 05, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 11 instances where the indicator turned negative. In 10 of the 11 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 90%.
The Momentum Indicator moved below the 0 level on November 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on DGNX as a result. In 20 of 24 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 83%.
DGNX moved below its 50-day moving average on November 04, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for DGNX crossed bearishly below the 50-day moving average on November 09, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 4 of 5 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 80%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DGNX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +6.67% 3-day Advance, the price is estimated to grow further. Considering data from situations where DGNX advanced for three days, in 87 of 99 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.
DGNX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 50 of 51 cases where DGNX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.
The Tickeron PE Growth Rating for this company is 43 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 45 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.159) is normal, around the industry mean (-1.939). P/E Ratio (-3.022) is within average values for comparable stocks, (9.673). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.843). Dividend Yield (0.000) settles around the average of (0.072) among similar stocks. P/S Ratio (9.950) is also within normal values, averaging (71.334).
The Tickeron Price Growth Rating for this company is 81 (best 1 - 100 worst), indicating slightly worse than average price growth. DGNX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DGNX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry PackagedSoftware